Showing results (331-340 of 554) with videos related to

Sort By:
Pageof 56
Prostate Cancer and Prostatic Diseases|June 20, 2025
Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variantMayuko Kanayama, Emeline Colomba, Yusra Shao, et al.
The Prostate|April 20, 2024
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancerCatherine H Marshall, Lukasz P Gondek, Violet Daniels, et al.
Cancers|May 13, 2026
Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy SensitivityAsaad Trabolsi, Marianna Lekakis, Peter M Commisso, et al.
Journal for Immunotherapy of Cancer|April 19, 2018
Microsatellite instability in prostate cancer by PCR or next-generation sequencingJennifer A Hempelmann, Christina M Lockwood, Eric Q Konnick, et al.
Cancer Chemotherapy and Pharmacology|November 10, 2016
Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancerBenjamin L Maughan, Daniel L Suzman, Brandon Luber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2020
Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotypeC Lu, A Terbuch, D Dolling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2016
Analytic Validation of RNA In Situ Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate CancerLiana B Guedes, Carlos L Morais, Fawaz Almutairi, et al.
Prostate Cancer and Prostatic Diseases|October 16, 2019
A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancerAshley E Ross, Paula J Hurley, Phuoc T Tran, et al.
NPJ Precision Oncology|January 20, 2026
Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapyGaurav Sharma, Yasmine Baca, Sanjay Goel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2023
Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE TrialsEmmanuel S Antonarakis, Sumit K Subudhi, Christopher M Pieczonka, et al.
Pageof 56